Navigation Links
Out-of-whack protein may boost Parkinson's

GAINESVILLE, Fla. A single change in a protein may play a role in whether someone develops Parkinsons disease, say University of Florida Genetics Institute researchers writing in a recent issue of the Proceedings of the National Academy of Sciences.

Scientists studying rats induced to display a form of Parkinsons disease discovered that a protein commonly found in brain cells can be toxic if at one pinpoint location in its amino acid structure it lacks a chemical compound called a phosphate.

When scientists used gene therapy to simulate a phosphate at this critical position, the rats brain cells didnt develop the Parkinson-like pathology that would normally occur.

The finding provides new insight into the fundamentals of Parkinsons disease and the role of an abundant yet mysterious brain protein known as alpha-synuclein, which is believed to help brain cells communicate but may have a more sinister role in the development of neurological diseases.

We have another potential target for therapy, but there is a great deal left to discover, said Nicholas Muzyczka, Ph.D., a professor of molecular genetics and microbiology in the College of Medicine and an eminent scholar with the UF Genetics Institute. This is one more piece of information about what might be causing the toxicity in Parkinsons disease, and it gives us a little more to go on about what alpha-synuclein does in the brain.

Generally located at the synapses of nerve cells, alpha-synuclein is believed to aid in brain function, possibly by helping cells communicate with one another by controlling the release of neurotransmitters such as dopamine.

Mutations of alpha-synuclein may cause a rare, inherited form of Parkinsons, and the protein has been found to be the major component of Lewy bodies, which are abnormal clusters of protein in the brain cells of patients with Parkinsons disease.

The National Parkinson Foundation estimates 1.5 million Americans currently have Parkinsons disease and about 60,000 new cases are diagnosed each year. It is caused by the death or impairment of certain nerve cells in a part of the brain called the substantia nigra. When these cells die, the body is deprived of dopamine, a neurotransmitter vital for movement.

We know of several enzymes that can cause phosphorylation in the proper position of the alpha-synuclein protein, said Oleg Gorbatyuk, Ph.D., an assistant professor of molecular genetics and microbiology. Increasing their expression in brains afflicted with Parkinsons disease could possibly provide a gene therapy approach to the disease.

In experiments described in the Jan. 15 issue of PNAS, UF researchers used gene transfer to enhance the production of three versions of alpha-synuclein in the substantia nigra region on one side of the rats brains. The other side was not treated, for comparison purposes.

Of the types of alpha-synuclein, the one that simulated phosphorylation at position 129 of the protein was nontoxic. But the other versions of the protein all caused significant loss of dopamine neurons in the substantia nigra.

Adding a phosphate group is about the smallest thing that can possibly happen in biology, said Mark R. Cookson, an investigator in the Cell Biology and Gene Expression Unit of the National Institute on Aging who was not involved in the research. But this relatively minor, innocuous change can switch everything around from being a big problem to being no problem. This research really gives us an idea of some things going on in inherited cases of Parkinsons disease, and if we use that genetic information as a handle to get into the common disease, it is possible to take this from genetics to a drug discovery program.


Contact: John D. Pastor
University of Florida

Related medicine news :

1. Scientists identify proteins that help bacteria put up a fight
2. Protein shines light on cancer response
3. 3 newly discovered ERK pathway proteins related to CagA induced disease
4. U of M researchers determine structure of protein that mutates DNA of the AIDS virus HIV-1
5. Oncoproteins double-team and destroy vital tumor-suppressor
6. Lack of Brain Protein May Explain Rain Man Abilities
7. Discovery of overdrive protein could broaden drug design options
8. Burn Fat with fucoPROTEIN(TM) Bars
9. Unsuspected protein determines resistance to breast cancer treatment
10. Breaking down Huntingtons disease one protein at a time
11. New findings show Enbrel significantly reduced levels of C-reactive protein
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
Breaking Medicine Technology: